Enteral Feeding Formulas Market Size, Trends, Shares, and Forecast - 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Enteral Feeding Formulas Market covers analysis by Type (Standard Formulas, Peptide Formulas, Specialized Formulas, and Others), Application (Respiratory Disorders, Cancer, Gastroenterology Disorders, Diabetes, Liver/Kidney Disease, Neurology, and Others), Form (Powder, Liquid, and Semi-Solid), Age Group [(Children (Till 18 Years) and Adult (18+ Years)], Distribution Channel (Hospital Pharmacies, Retail Stores, and Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Sep 2025
  • Report Code : TIPRE00003840
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The enteral feeding formulas market is expected to grow from US$ 7,803.45 million in 2021 to US$ 11,726.37 million by 2031 at a CAGR of 6.0% between 2022 and 2031.

Crohn’s disease, gastrointestinal disease due to trauma, bowel obstruction (BO), microscopic colitis, short bowel syndrome, and ulcerative colitis are a few gastrointestinal diseases. According to the article in Heathline, in 2021, around 40% of people across the world were affected by functional gastrointestinal disorder. According to Medscape, in developed countries, the most common cause of small-bowel obstruction (SBO) is intra-abdominal adhesions, accounting for ~65 to 75% of cases, followed by hernias. In contrast, in developing countries, SBO is primarily caused by hernias (30–40%), adhesions (about 30%), and tuberculosis (about 10%). According to the article published by World Journal of Emergency Surgery, bowel obstruction is an important cause of morbidity and mortality accounting for nearly 30,000 deaths and more than US$3 billion per year in direct medical costs. Bowel obstruction is responsible for ~15% of hospital admissions for acute abdominal pain in the US, and ~ 20% of cases need acute surgical care.

Crohn’s disease is a complex, long-lasting (chronic) disorder that primarily affects the digestive system. It is most common disease in North America and Western Europe and has a prevalence of 100 to 300 per 100,000 in these regions. According to Medline Plus, more than half a million in North American and Western European people are currently suffering from Crohn’s disease. Patients suffering from gastrointestinal disease are at an increased risk of nutritional deterioration due to fasting for the diagnostic tests, therapeutic dietary restriction, and appetite loss due to anorexia or altered nutritional requirement. Gastrointestinal disease patients cannot consume food orally. Therefore, enteral route is preferred to provide the required nutrients. A few brands that caters to gastroenterology disorders are Ensure, Ensure HN, Ensure Powder, Isocal, Lonalac Powder, Meritene, Meritene Powder, Osmolite, Osmolite HN, Portagen Powder, Sustacal, Sustagen Powder, and Travasorb.  Therefore, the growing prevalence of gastrointestinal diseases drives the growth of the enteral feeding formulas market

MARKET DYNAMICS


The growth of the enteral feeding formulas market is majorly attributed to the rising prevalence of gastrointestinal disorders and the increasing prevalence of cachexia. However, mechanical or enteral tube-related problems hamper the growth of the market. The usage of next-generation technology for proper enteral nutrition feeding is projected to offer lucrative opportunities for the growth of the enteral feeding formulas market during the forecast period.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Enteral Feeding Formulas Market: Strategic Insights

global-enteral-feeding-formulas-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

MARKET SCOPE


The "Global Enteral Feeding Formulas Market Analysis to 2031"  report aims to provide an overview of enteral feeding formulas market with detailed market segmentation based on type, application, form, age group, and distribution channel. The report provides key statistics based on the financial performances of the leading enteral feeding formulas market players. It also offers key trends and opportunities in the market.

MARKET SEGMENTATION


The global enteral feeding formulas market is segmented on the basis of type, application, form, age group, and distribution channel. Based on type, the market is segmented into standard formulas, peptide formulas, specialized formulas, and others. By application, the market is segmented into respiratory disorders, cancer, gastroenterology disorders, diabetes, liver/kidney disease, neurology, post COVID-19, and others. Based on form, the enteral feeding formulas market is segmented into powder, liquid, and semi-solid. Based on age group, the market is bifurcated into adult (18+ years) and children (till 18 years). In terms of distribution channel, the market is segmented into hospital pharmacies, retail stores, and others.

REGIONAL FRAMEWORK


The global enteral feeding formulas market is segmented into five major regions—North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report covers analysis and forecast of 18 countries globally along with trends and opportunities prevailing in the regions.

North America dominated the enteral feeding formulas market capturing more than 41% market share in 2021. The market growth in North America is driven by the growing prevalence of gastroenterology disorders in the US.  According to Centers for Disease Control and prevention, the number of adults with diagnosed ulcers in the United States was 14.8 million in 2021. The number of visits to emergency departments with diseases of the digestive system as the primary diagnosis was 7.9 million in 2021 in the United States. As a result, the enteral feeding formulas acts as a medium to overcome or prevent such illnesses owing to the source of nutrients (protein, carbohydrates, etc.) received from the enteral feeding formula products.

 The below figure shows the revenue growth trend in the enteral feeding formulas market:

The report analyzes factors, such as drivers, restraints, opportunities, and future trends, which impact the growth of the enteral feeding formulas market. It also provides exhaustive Porter's five forces analysis of the factors influencing the market.

IMPACT OF COVID-19 PANDEMIC

According to a research article published in Critical Care, 2021, the novel coronavirus may invade the gastrointestinal tract, neurological systems, and kidneys, which may adversely affect the nutrition delivery among COVID-19 patients. As per the guidelines by the European Society for Clinical Nutrition and Metabolism (ESPEN) on nutrition in the ICU, gastric/renal enteral formulas are recommended for severe COVID-19 patients admitted in the intensive care units (ICUs). Hence, the demand for enteral feeding formulas increased globally due to the rising number of COVID-19 patients, especially in ICUs.

MARKET PLAYERS


The report covers key developments in the enteral feeding formulas market. Various companies are focusing on organic growth strategies, such as product launches, product approvals, and patents and events. In addition, acquisitions, and partnership & collaborations are among the inorganic growth strategies witnessed in the market. These activities have paved way for the expansion of business and customer base of market players. The players operating in the enteral feeding formulas market are anticipated to experience lucrative growth opportunities in the future owing to the rising demand for enteral feeding formulas.

The report also includes the profiles of key enteral feeding formulas market companies along with their SWOT analysis and market strategies. In addition, it focuses on leading industry players with information, such as company profiles, components and services offered, financial information of last 3 years, and key development in past five years.

Below mentioned is the list of a few companies engaged in the enteral feeding formulas market.

  • Abbott
  • Nestle Health Science
  • Magnacal Renal
  • UNILEVER
  • Danone
  • Kate Farms
  • Nutricia
  • Smartfish AS
  • Fresenius Kabi AG
  • Hormel Foods Corporation

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Report Scope

Enteral Feeding Formulas Market Regional Insights

The regional trends and factors influencing the Enteral Feeding Formulas Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Enteral Feeding Formulas Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

global-enteral-feeding-formulas-market-global-geography
  • Get the Regional Specific Data for Enteral Feeding Formulas Market

Enteral Feeding Formulas Market Report Scope

Report Attribute Details
Market size in 2024 US$ 9.3 Billion
Market Size by 2031 US$ 13.97 Billion
Global CAGR (2025 - 2031) 6.00%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Standard Formulas
  • Peptide Formulas
  • Specialized Formulas
By Application
  • Respiratory Disorders
  • Cancer
  • Gastroenterology Disorders
  • Diabetes
  • Liver/Kidney Disease
  • Neurology
  • Post COVID-19
By Form
  • Powder
  • Liquid
  • Semi-Solid
By Age Group
  • Children
  • Adult
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott
  • B. Braun Melsungen AG
  • Danone
  • Fresenius Kabi India Pvt. Ltd
  • Global Health Products, Inc.
  • Mead Johnson and Company, LLC
  • Meiji Holdings Co., Ltd.
  • Nestlé
  • Hormel Foods Corporation

  • Enteral Feeding Formulas Market Players Density: Understanding Its Impact on Business Dynamics

    The Enteral Feeding Formulas Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Enteral Feeding Formulas Market are:

    1. Abbott
    2. B. Braun Melsungen AG
    3. Danone
    4. Fresenius Kabi India Pvt. Ltd
    5. Global Health Products, Inc.

    Disclaimer: The companies listed above are not ranked in any particular order.


    global-enteral-feeding-formulas-market-cagr

    • Get the Enteral Feeding Formulas Market top key players overview
    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies

    1. Abbott
    2. B. Braun Melsungen AG
    3. Danone
    4. Fresenius Kabi India Pvt. Ltd
    5. Global Health Products, Inc.
    6. Mead Johnson and Company, LLC
    7. Meiji Holdings Co., Ltd.
    8. Nestlé
    9. Hormel Foods Corporation
    10. Victus, Inc

    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo